Clinical Trial

Evaluating the Impact of CONNECT in a Multilingual Population

Study acronym: CONNECT-ML
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to broaden the reach of the lung cancer screening (LCS) CONNECT program (NCT04149249, NCT06213532), by developing a version of the program to be available to multilingual communities. The CONNECT program encourages individuals who are undergoing lung cancer screening to also quit smoking by providing a personalized program which includes a video doctor with personalized responses, text message and telephone call support and connection with a pharmacist to assist in obtaining nicotine replacement medication. This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation among current adult smokers within the Spanish and Cantonese speaking communities.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-14
Trial Details
NCT Number NCT07111936
Lead Sponsor University of California, San Francisco
Collaborators: Tobacco Related Disease Research Program
Conditions Smoking Cessation, Smoking Cessation Counseling Ability and Practice, Smoking Cessation Counselling, Lung Cancer Screening
Enrollment 439 participants
Start Date 2025-08-07
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-13